Investment Summary

Symrise Invests In Cellibre

On October 22, 2025, Symrise invested in life science company Cellibre

Investment Highlights
  • This is Symrise’s 2nd transaction in the Life Science sector.
  • This is Symrise’s 9th transaction in the United States.
  • This is Symrise’s 1st transaction in California.

Investment Summary

Date 2025-10-22
Target Cellibre
Sector Life Science
Investor(s) Symrise
Deal Type Growth Capital

Target

Cellibre

San Diego, California, United States
Cellibre develops biomanufacturing technology that uses cellular engineering and precision fermentation to produce sustainable, high-value ingredients. The Company applies strain design, protein optimization, and fermentation processes to create bio-based alternatives for industries such as nutrition, pharmaceuticals, and specialty chemicals. Cellibre was founded in 2018 and is headquartered in San Diego, California.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Symrise

Holzminden, Germany

Category Company
Founded 1874
Sector Chemicals
Employees12,984
Revenue 5.0B EUR (2024)
DESCRIPTION

Symrise is a producer of flavours, fragrances, cosmetic ingredients and aroma chemicals in the world. Symrise was founded in 1874 and is based in Holzminden, Germany.


DEAL STATS #
Overall 15 of 15
Sector: Life Science M&A 2 of 2
Type: Growth Capital M&A Deals 2 of 2
State: California M&A 1 of 1
Country: United States M&A 9 of 9
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-07-13 Bonumose

Charlottesville, Virginia, United States

Bonumose is a food ingredient manufacturer that specializes in the affordable production of delicious, good-for-you rare monosaccharides (alternatives to sucrose) such as tagatose and allulose. Bonumose was formed in 2016 and is based in Charlottesville, Virginia.

Buy -